Document Detail

Effect of the insulin sensitizers metformin and pioglitazone on endothelial function in young women with polycystic ovary syndrome: a prospective randomized study.
MedLine Citation:
PMID:  20684955     Owner:  NLM     Status:  In-Process    
OBJECTIVE: To compare the effect of two different insulin sensitizers, metformin and pioglitazone, on endothelial function in women with polycystic ovary syndrome (PCOS).
DESIGN: Prospective randomized study.
SETTING: University Hospital endocrinology outpatient clinic.
PATIENT(S): Young women with PCOS (aged 23.3±4.9 years).
INTERVENTION(S): Patients were assigned randomly to no treatment (n=14), metformin 850 mg two times per day (n=15), and pioglitazone 30 mg daily (n=14) for 6 months. Healthy age- and body mass index-matched women served as controls (n=14).
MAIN OUTCOME MEASURE(S): Brachial artery flow-mediated dilation was studied at baseline and 6 months.
RESULT(S): Women with PCOS had higher insulin resistance and hyperandrogenism indices and lower flow-mediated dilation compared with controls. The three groups of women with PCOS did not differ at baseline. No differences were observed at follow-up in women who received no treatment. Metformin and pioglitazone improved flow-mediated dilation to a similar extent, restoring it to normal values at 6 months. Both insulin sensitizers induced favorable changes in insulin resistance and hyperandrogenism indices in women with PCOS. Independent predictors of flow-mediated dilation improvement at 6 months were treatment with insulin sensitizers and reduction in insulin resistance.
CONCLUSION(S): In young women with PCOS, treatment with metformin or pioglitazone for 6 months induces a similar beneficial effect on endothelial function; this may be partially attributed to an improvement in insulin resistance. Further research is needed to investigate whether treatment with insulin sensitizers in women with PCOS also reduces cardiovascular risk.
Katerina K Naka; Sophia N Kalantaridou; Maria Kravariti; Aris Bechlioulis; Nikolaos Kazakos; Karim A Calis; Antonis Makrigiannakis; Christos S Katsouras; George P Chrousos; Agathocles Tsatsoulis; Lampros K Michalis
Related Documents :
24757395 - Hyperlipidemia as a risk factor for persons in specific professions.
20536945 - Type 2 diabetes and cardiovascular disease in polycystic ovary syndrome: what are the r...
19501355 - Not all women diagnosed with pcos share the same cardiovascular risk profiles.
17353865 - Polycystic ovarian syndrome: the commonest cause of hyperandrogenemia in women as a ris...
7641355 - Long-term (5-year) changes in hdl cholesterol in cardiac rehabilitation patients. do se...
9436895 - Predictors of recovery in activities of daily living among disabled older persons livin...
Publication Detail:
Type:  Journal Article     Date:  2010-08-04
Journal Detail:
Title:  Fertility and sterility     Volume:  95     ISSN:  1556-5653     ISO Abbreviation:  Fertil. Steril.     Publication Date:  2011 Jan 
Date Detail:
Created Date:  2010-12-20     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0372772     Medline TA:  Fertil Steril     Country:  United States    
Other Details:
Languages:  eng     Pagination:  203-9     Citation Subset:  IM    
Copyright Information:
Copyright © 2011 American Society for Reproductive Medicine. All rights reserved.
Michaelidion Cardiac Center, Department of Cardiology, University of Ioannina, Ioannina, Greece.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Gonadotropin-releasing hormone agonists versus antagonists for controlled ovarian hyperstimulation i...
Next Document:  Altered levels of seminal nitric oxide, nitric oxide synthase, and enzymatic antioxidants and their ...